Categories
All News

HLA Typing for Transplant Market Opportunities, Size, Top Manufacturers – QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US)

HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) – Global Forecast to 2025

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3031601

The global HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. The demand for HLA typing products for transplant is expected to grow due to technological advancements in the field of HLA typing and increasing public-private funding for target research activities.The HLA typing for the transplants market is segmented on the product, technology, application, end-user, and region.

Some of the prominent players in the HLA typing for transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), and Omixon (Hungary).

HLA Typing for Transplant Market is a proficient and comprehensive marketing report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. Nowadays, businesses get highly benefited with the different segments covered in the market research report which makes available better market insights to them with which they can drive the business into right direction. This market report covers an array of aspects of the market analysis which today’s businesses call for. The HLA Typing for Transplant Market report is produced with the systematic gathering and analysis of information about individuals or organisations which is conducted through social and opinion research.

“The independent reference laboratories segment accounted for the largest share of the HLA typing for transplants market,by end-user,in 2019.”

Based on end user, the HLA typing for transplants market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes.In 2019, independent reference laboratories accounted for the largest share of the HLA typing for transplants market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

“The molecular assay technologies segment accounted for the largest share of the HLA typing for transplants market,by technology, in 2019.”

The HLA typing for transplants market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the HLA typing for transplants market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.

“North America accounted for the largest share of the HLA typing for transplants market in 2019.”

North America accounted for the largest share of the HLA typing for transplants market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies (includes HLA typing), well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1(48%), Tier 2(36%), and Tier 3(16%)
  • By Designation: C-level(10%), Director-level(14%), and Others(76%)
  • By Region: North America(40%), Europe(32%), APAC(20%), and RoW(8%)

Research Coverage

This report studies the HLA typing for transplants market based on product, technology, application, end-user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It the the with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape users emerging segments of the HLA typing for transplants market;and high-growth regions and their drivers, restraints, challenges, and opportunities.The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

For More Information or Query or Customization Before Buying, Visit @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=3031601

Table of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency Used For The Study
1.5 Major Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Procedure-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary

4 Premium Insights
4.1 Hla Typing For Transplants Market Overview
4.2 Hla Typing For Transplants Market, By Technology
4.3 Regional Analysis: Hla Typing For Transplants Market, By Application
4.4 Asia Pacific: Hla Typing For Transplants Market, By End User, 2019
4.5 Regional Analysis: Hla Typing For Transplants Market, By Product & Service
4.6 Hla Typing For Transplants Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Increasing Number Of Transplant Procedures
5.2.1.2 Technological Advancements In The Field Of Hla Typing
5.2.1.3 Increasing Public-Private Funding For Target Research Activities
5.2.2 Key Market Restraints
5.2.2.1 High Costs Of Molecular Tests Used For Hla Typing Procedures
5.2.2.2 Limited Reimbursements For Target Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Rising Adoption Of Cross-Matching And Chimerism Testing During Pre- & Post-Transplantation
5.2.3.2 Technological Shift From Non-Molecular Serological Assays To Gene-Based Hla Profiling
5.2.3.3 Increasing Public Awareness About Organ Donation And Transplantation Across Emerging Countries
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between The Number Of Organ Donors And Organs Required Annually

6 Hla Typing For Transplants Market, By Product & Service
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Increasing Patient Emphasis On Effective Patient Profiling During Organ Transplantation To Drive Market Growth
6.3 Instruments
6.3.1 Increasing Patient Awareness About The Benefits Offered By Genome-Based Profiling Will Support Market Growth
6.4 Software & Services
6.4.1 Rising Demand For Innovative Hla Typing Software During The Detection Of Specific Alleles Is Supporting Market Growth

7 Hla Typing For Transplants Market, By Technology
7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 Pcr-Based Molecular Assays
7.2.1.1 Sequence-Specific Oligonucleotide-Pcr
7.2.1.1.1 Growing Awareness About The Benefits Offered By Sso-Pcr Among Medical Professionals To Drive Market Growth
7.2.1.2 Sequence-Specific Primer-Pcr
7.2.1.2.1 Growing Public-Private Investments For Research Activities To Support Market Growth
7.2.1.3 Real-Time Pcr
7.2.1.3.1 High Cost Of Real-Time Pcr And Procedural Complexity To Hamper Market Growth
7.2.1.4 Other Pcr-Based Molecular Assays
7.2.2 Sequencing-Based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.1.1 Growing Demand For High-Throughput Dna Sequencers To Drive Market Growth
7.2.2.2 Next-Generation Sequencing
7.2.2.2.1 Expansion In The Application Horizons Of Ngs In The Field Of Tissue Typing To Support Market Growth
7.2.2.3 Other Sequencing-Based Molecular Assays
7.3 Non-Molecular Assay Technologies
7.3.1 Replacement Of Non-Molecular Assay Techniques With Dna-Based Hla Typing Procedures Is Expected To Hamper Market Growth

8 Hla Typing For Transplants Market, By Application
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Antibody Screening
8.2.1.1 Rising Number Of Recipients For Transplant Procedures To Drive Market Growth
8.2.2 Chimerism Monitoring
8.2.2.1 Rising Trend Of Personalized Transplant Medicine For Effective Post-Procedural Clinical Risk Management To Drive Market Growth
8.2.3 Other Applications
8.3 Research Applications
8.3.1 Increasing Identification Of New Genes & Biomarkers In Donor-Recipient Cross Match Will Drive The Market Growth

9 Hla Typing For Transplants Market, By End User
9.1 Introduction
9.2 Independent Reference Laboratories
9.2.1 Increasing Number Of Preventive Genomic Clinics To Drive Market Growth
9.3 Hospitals & Transplant Centers
9.3.1 Healthcare Consolidation And Establishment Of New Hospitals To Support Market Growth
9.4 Research Laboratories & Academic Institutes
9.4.1 Growing Awareness About The Research Applications In Transplant Rejection Monitoring To Drive Market Growth

10 Hla Typing For Transplants Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 Ongoing Technological Advancements In The Field Of Hla Typing To Drive Market Growth In The Us
10.2.2 Canada
10.2.2.1 Growing Availability Of Hla Typing Products To Support Market Growth In Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted For The Largest Share Of The European Market
10.3.2 Uk
10.3.2.1 Rising Number Of Transplantation Procedures To Drive Market Growth In The Uk
10.3.3 France
10.3.3.1 Adoption Of Molecular Diagnostic Techniques For Donor-Recipient Compatibility Testing Is Increasing In France
10.3.4 Italy
10.3.4.1 Sluggish Growth In The Italian Healthcare Sector In The Last Few Years To Restrain Market Growth
10.3.5 Spain
10.3.5.1 Rising Number Of Solid Organ Transplantation Procedures To Drive Market Growth In Spain
10.3.6 Rest Of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Significant Growth In Chronic Disease Prevalence To Support Market Growth In Japan
10.4.2 China
10.4.2.1 Healthcare Infrastructure Improvements To Support Market Growth In China
10.4.3 India
10.4.3.1 Increasing Number Of Transplantation Procedures To Drive Market Growth In India
10.4.4 Australia
10.4.4.1 Rising Number Of Solid Organ Transplantation Procedures To Support Market Growth In Australia
10.4.5 South Korea
10.4.5.1 Government Initiatives To Introduce Medical Coverage For Transplantation To Support Market Growth In South Korea
10.4.6 Rest Of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 Brazil Accounted For The Largest Share Of The Latam Market
10.5.2 Mexico
10.5.2.1 Rising Medical Tourism To Support Market Growth In Mexico
10.5.3 Rest Of Latin America
10.6 Middle East And Africa

11 Competitive Landscape

Purchase the Report Directly @ https://www.reportsnreports.com/purchase.aspx?name=3031601

https://bisouv.com/